These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15977960)

  • 1. Facilitating adherence to highly active antiretroviral therapy in children with HIV infection: what are the issues and what can be done?
    Pontali E
    Paediatr Drugs; 2005; 7(3):137-49. PubMed ID: 15977960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence issues in children and adolescents receiving highly active antiretroviral therapy.
    Goode M; McMaugh A; Crisp J; Wales S; Ziegler JB
    AIDS Care; 2003 Jun; 15(3):403-8. PubMed ID: 12745395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.
    Martin S; Elliott-DeSorbo DK; Wolters PL; Toledo-Tamula MA; Roby G; Zeichner S; Wood LV
    Pediatr Infect Dis J; 2007 Jan; 26(1):61-7. PubMed ID: 17195708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dealing with the obstacles in adhering to highly active antiretroviral therapy.
    Hubbard M
    J Assoc Nurses AIDS Care; 2006; 17(1):18-25. PubMed ID: 16686081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caregiver psychosocial characteristics and children's adherence to antiretroviral therapy.
    Marhefka SL; Tepper VJ; Brown JL; Farley JJ
    AIDS Patient Care STDS; 2006 Jun; 20(6):429-37. PubMed ID: 16789856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-adherence to highly active antiretroviral therapy in children attending HIV treatment clinic at harare Children's Hospital, Zimbabwe.
    Chimhuya S; Nathoo KJ; Rusakaniko S
    Cent Afr J Med; 2013; 59(9-12):63-70. PubMed ID: 29144622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study.
    Hammami N; Nöstlinger C; Hoerée T; Lefèvre P; Jonckheer T; Kolsteren P
    Pediatrics; 2004 Nov; 114(5):e591-7. PubMed ID: 15520091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.
    Azmeraw D; Wasie B
    Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antiretroviral therapy among older children and adolescents with HIV: a qualitative study of psychosocial contexts.
    Merzel C; VanDevanter N; Irvine M
    AIDS Patient Care STDS; 2008 Dec; 22(12):977-87. PubMed ID: 19072104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to high activity antiretrovial therapy (HAART) in pediatric patients infected with HIV: issues and interventions.
    Shah CA
    Indian J Pediatr; 2007 Jan; 74(1):55-60. PubMed ID: 17264455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to antiretrovirals in HIV disease.
    Cinti SK
    AIDS Read; 2000 Dec; 10(12):709-17. PubMed ID: 11189742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a comprehensive program including psycho-social and treatment literacy activities to improve adherence to HIV care and treatment for a pediatric population in Kenya.
    Van Winghem J; Telfer B; Reid T; Ouko J; Mutunga A; Jama Z; Vakil S
    BMC Pediatr; 2008 Nov; 8():52. PubMed ID: 19025581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to HAART regimens.
    Chesney M
    AIDS Patient Care STDS; 2003 Apr; 17(4):169-77. PubMed ID: 12737640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of adherence management in human immunodeficiency virus pharmacotherapy.
    Park-Wyllie LY; Phillips EJ
    Can J Clin Pharmacol; 2003; 10(4):189-95. PubMed ID: 14712324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.